checkAd
    Royalty Pharma Registered (A) Aktie
    26,87
     
    EUR
    +3,49 %
    +0,91 EUR
    Letzter Kurs 02.05.24 Lang & Schwarz
    26,74
     
    EUR
    185 STK
    Geldkurs 02.05.24
    26,99
     
    EUR
    185 STK
    Briefkurs 02.05.24
    ISIN: GB00BMVP7Y09 · WKN: A2P62D · Großbritannien

    Neueste Nachrichten

    Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
    19.04.24 · globenewswire · Royalty Pharma Registered (A)
    Royalty Pharma Declares Second Quarter 2024 Dividend
    17.04.24 · globenewswire · Royalty Pharma Registered (A)
    wO Börsenlounge: Apple | Tesla | Adidas - Startschuss für Cannabis-Aktien gefallen?
    22.03.24 · Markus Weingran · Apple
    Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
    28.02.24 · globenewswire · Royalty Pharma Registered (A)
    Royalty Pharma Reports Q4 and Full Year 2023 Results
    15.02.24 · globenewswire · Royalty Pharma Registered (A)
    Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024
    30.01.24 · globenewswire · Royalty Pharma Registered (A)
    Royalty Pharma Announces Dividend Increase
    19.01.24 · globenewswire · Royalty Pharma Registered (A)
    Fokus Aktien mit extremen Handelsvolumen am Freitag, den 12.01.2024
    12.01.24 · wO Chartvergleich · Canon
    Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
    08.01.24 · globenewswire · Royalty Pharma Registered (A)
    Royalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx Conference
    27.11.23 · globenewswire · Royalty Pharma Registered (A)
    Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program
    13.11.23 · globenewswire · Royalty Pharma Registered (A)
    Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program
    13.11.23 · Business Wire (engl.) · Teva Pharmaceutical Industries